3002.51.00.00 - Cell therapy products 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | Free |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS subheading, 3002.51.00.00, specifically covers products derived from cell therapy. Cell therapy involves the use of living cells, often manipulated or modified, for therapeutic or diagnostic purposes in humans or animals. This includes a wide range of biological products where the active therapeutic agent is a cellular component, such as stem cells, immune cells, or genetically engineered cells, administered to treat or prevent disease.
This category is distinguished from its sibling, 3002.59.00.00 ("Other"), by its exclusive focus on cell therapy products. While both fall under the broader heading of "cell cultures, whether or not modified," 3002.51.00.00 is for products where the cellular material itself is the primary therapeutic agent. The "Other" category would encompass different types of cell cultures or related products that do not fit the specific definition of cell therapy.
As this is a leaf node in the HTS, there are no further subcategories. Therefore, classification within 3002.51.00.00 depends on the specific nature and intended use of the cellular product. Examples include autologous or allogeneic cell transplants, engineered cell therapies for cancer treatment, and regenerative medicine products based on cultured cells, provided they meet the criteria for therapeutic or diagnostic application.